Dawn A Svoronos's most recent trade in Adverum Biotechnologies Inc was a trade of 10,450 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,450 | 10,450 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 17,012 | 17,012 | - | - | Share Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 2,645 | 2,645 | - | - | Restricted Share Units | |
| Adverum Biotechnologies Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 10,520 | 10,520 | - | - | Stock Option (Right to Buy) | |
| Acelyrin Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 92,158 | 92,158 | - | - | Director Stock Option (right to buy) | |
| Xenon Pharmaceuticals Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 15,542 | 15,542 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Dawn A. Svoronos | Director | Sale of securities on an exchange or to another person at price $ 38.70 per share. | 24 Aug 2023 | 25,000 | 25,000 (0%) | 0% | 38.7 | 967,500 | Common Shares |
| Adverum Biotechnologies Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 18,475 | 18,475 | - | - | Stock Option (Right to Buy) | |
| Acelyrin Inc | Dawn A. Svoronos | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 155,450 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Dawn A. Svoronos | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 155,450 | 155,450 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Dawn A. Svoronos | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 23,243 | 0 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Dawn A. Svoronos | Director | Other type of transaction at price $ 0.00 per share. | 09 May 2023 | 23,243 | 23,243 | - | - | Director Stock Option (right to buy) | |
| Acelyrin Inc | Dawn A. Svoronos | Director | Purchase of securities on an exchange or from another person at price $ 18.00 per share. | 09 May 2023 | 15,000 | 15,000 | - | 18 | 270,000 | Common Stock |
| Acelyrin Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 23,243 | 23,243 | - | - | Director Stock Option (right to buy) | |
| Xenon Pharmaceuticals Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Dawn A. Svoronos | Director | Sale of securities on an exchange or to another person at price $ 27.20 per share. | 09 Jun 2022 | 738 | 29,017 (0%) | 0% | 27.2 | 20,074 | Common Stock |
| Adverum Biotechnologies Inc | Dawn A. Svoronos | Director | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 16 May 2022 | 30,000 | 50,000 (0%) | 0% | 0.9 | 25,578 | Common Stock |
| PTC Therapeutics Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 29,755 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Dawn A. Svoronos | Director | Sale of securities on an exchange or to another person at price $ 38.53 per share. | 07 Jan 2022 | 510 | 26,555 (0%) | 0% | 38.5 | 19,648 | Common Stock |
| Xenon Pharmaceuticals Inc | Dawn A. Svoronos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |